[
  {
    "ts": null,
    "headline": "WST's Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up",
    "summary": "West Pharmaceutical beats Q4 EPS and revenue estimates as proprietary products drive growth, while shares jump nearly 3.6% premarket on upbeat 2026 outlook.",
    "url": "https://finnhub.io/api/news?id=826b1970c7be4dc99a19ce00aa9f9bdc8b5645cc5c36269a693d02b22dd52d53",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770919620,
      "headline": "WST's Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up",
      "id": 139073388,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical beats Q4 EPS and revenue estimates as proprietary products drive growth, while shares jump nearly 3.6% premarket on upbeat 2026 outlook.",
      "url": "https://finnhub.io/api/news?id=826b1970c7be4dc99a19ce00aa9f9bdc8b5645cc5c36269a693d02b22dd52d53"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services, Inc. Q4 2025 Earnings Call Summary",
    "summary": "Moby summary of West Pharmaceutical Services, Inc.'s Q4 2025 earnings call",
    "url": "https://finnhub.io/api/news?id=6e78f9c7f03e78b199a2c403e32508bc6526d29bd66e2d82fbc199a88c876e35",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770917560,
      "headline": "West Pharmaceutical Services, Inc. Q4 2025 Earnings Call Summary",
      "id": 139067479,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "Moby summary of West Pharmaceutical Services, Inc.'s Q4 2025 earnings call",
      "url": "https://finnhub.io/api/news?id=6e78f9c7f03e78b199a2c403e32508bc6526d29bd66e2d82fbc199a88c876e35"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical (WST) Reports Q4 Earnings: What Key Metrics Have to Say",
    "summary": "Although the revenue and EPS for West Pharmaceutical (WST) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "url": "https://finnhub.io/api/news?id=db4d65c1e3a649c04032b2c28764990964a6db193c096108725871313ffbfe98",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770906606,
      "headline": "West Pharmaceutical (WST) Reports Q4 Earnings: What Key Metrics Have to Say",
      "id": 139067480,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "Although the revenue and EPS for West Pharmaceutical (WST) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
      "url": "https://finnhub.io/api/news?id=db4d65c1e3a649c04032b2c28764990964a6db193c096108725871313ffbfe98"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings Call Transcript",
    "summary": "West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings Call February 12, 2026 8:00 AM ESTCompany ParticipantsJohn Sweeney - Vice President of Investor...",
    "url": "https://finnhub.io/api/news?id=047f2cdd2ca2aabe47a6c7b1f308daa9509579492fbeeaa2e6aa1bd6fcf69109",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770905659,
      "headline": "West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings Call Transcript",
      "id": 139072469,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "WST",
      "source": "SeekingAlpha",
      "summary": "West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings Call February 12, 2026 8:00 AM ESTCompany ParticipantsJohn Sweeney - Vice President of Investor...",
      "url": "https://finnhub.io/api/news?id=047f2cdd2ca2aabe47a6c7b1f308daa9509579492fbeeaa2e6aa1bd6fcf69109"
    }
  },
  {
    "ts": null,
    "headline": "Get insights into the top movers in the S&P500 index of Thursday's pre-market session.",
    "summary": "Pre-market stock analysis of S&P500 stocks on 2026-02-12: top gainers and losers in today's session.",
    "url": "https://finnhub.io/api/news?id=ecc7680c4ce2d203da29eb100d27d445dbb64bd87cab69104698a1f6f088ee2b",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770903304,
      "headline": "Get insights into the top movers in the S&P500 index of Thursday's pre-market session.",
      "id": 139055479,
      "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
      "related": "WST",
      "source": "ChartMill",
      "summary": "Pre-market stock analysis of S&P500 stocks on 2026-02-12: top gainers and losers in today's session.",
      "url": "https://finnhub.io/api/news?id=ecc7680c4ce2d203da29eb100d27d445dbb64bd87cab69104698a1f6f088ee2b"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services (NYSE:WST) Beats Q4 Earnings Estimates, Shares Surge",
    "summary": "West Pharmaceutical Services beats Q4 earnings estimates, driven by strong high-value product sales, leading to a significant stock price increase.",
    "url": "https://finnhub.io/api/news?id=87d133314f68e7fb872cbdef86335d33647c2098065613094398b15e223765a8",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770899582,
      "headline": "West Pharmaceutical Services (NYSE:WST) Beats Q4 Earnings Estimates, Shares Surge",
      "id": 139054933,
      "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_16_065e226ebd.webp",
      "related": "WST",
      "source": "ChartMill",
      "summary": "West Pharmaceutical Services beats Q4 earnings estimates, driven by strong high-value product sales, leading to a significant stock price increase.",
      "url": "https://finnhub.io/api/news?id=87d133314f68e7fb872cbdef86335d33647c2098065613094398b15e223765a8"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services (WST) Tops Q4 Earnings and Revenue Estimates",
    "summary": "West Pharmaceutical (WST) delivered earnings and revenue surprises of +11.21% and +1.35%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=2a8fa428ab836c974f275e10b40f6e440b44575f2208636eb72e27957f3df90c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770898202,
      "headline": "West Pharmaceutical Services (WST) Tops Q4 Earnings and Revenue Estimates",
      "id": 139056439,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical (WST) delivered earnings and revenue surprises of +11.21% and +1.35%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=2a8fa428ab836c974f275e10b40f6e440b44575f2208636eb72e27957f3df90c"
    }
  },
  {
    "ts": null,
    "headline": "West Pharma forecasts 2026 profit above estimates on strong demand for drug components",
    "summary": "Feb 12 () - West Pharmaceutical forecast annual profit above Wall Street estimates on Thursday, after beating fourth-quarter expectations on ‌strong demand for its proprietary products, which include syringes ‌and cartridges for injectable drugs. Shares of the Pennsylvania-based firm were up 3.",
    "url": "https://finnhub.io/api/news?id=79c768554624592ed9063aad55235c916f0dce5c552d8a993c8ea3745bb86012",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770897721,
      "headline": "West Pharma forecasts 2026 profit above estimates on strong demand for drug components",
      "id": 139055894,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "Feb 12 () - West Pharmaceutical forecast annual profit above Wall Street estimates on Thursday, after beating fourth-quarter expectations on ‌strong demand for its proprietary products, which include syringes ‌and cartridges for injectable drugs. Shares of the Pennsylvania-based firm were up 3.",
      "url": "https://finnhub.io/api/news?id=79c768554624592ed9063aad55235c916f0dce5c552d8a993c8ea3745bb86012"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services’s (NYSE:WST) Q4 CY2025: Beats On Revenue, Stock Soars",
    "summary": "Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.5% year on year to $805 million. The company expects the full year’s revenue to be around $3.25 billion, close to analysts’ estimates. Its non-GAAP profit of $2.04 per share was 11.5% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=d1723774b83480a2808937998527671fbb0dbb3e30a405347c81689e137a4c96",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770894673,
      "headline": "West Pharmaceutical Services’s (NYSE:WST) Q4 CY2025: Beats On Revenue, Stock Soars",
      "id": 139056441,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.5% year on year to $805 million. The company expects the full year’s revenue to be around $3.25 billion, close to analysts’ estimates. Its non-GAAP profit of $2.04 per share was 11.5% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=d1723774b83480a2808937998527671fbb0dbb3e30a405347c81689e137a4c96"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical: Q4 Earnings Snapshot",
    "summary": "The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $1.83 per share. The medical device company posted revenue of $805 million in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected $794.3 million.",
    "url": "https://finnhub.io/api/news?id=bbd6affef847f9e40bb171beef62ad60ccac5cb7ca1c1c5b4d4877c68f41c84c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770894635,
      "headline": "West Pharmaceutical: Q4 Earnings Snapshot",
      "id": 139054716,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $1.83 per share. The medical device company posted revenue of $805 million in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected $794.3 million.",
      "url": "https://finnhub.io/api/news?id=bbd6affef847f9e40bb171beef62ad60ccac5cb7ca1c1c5b4d4877c68f41c84c"
    }
  },
  {
    "ts": null,
    "headline": "West Reports Fourth-Quarter and Full-Year 2025 Results",
    "summary": "West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today reported its financial results for the fourth quarter and full year 2025.",
    "url": "https://finnhub.io/api/news?id=b09da6017c07450a4b48b89ecf0eeedaa5000dbcd3a9f712c8a48b0ae555a78c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770894000,
      "headline": "West Reports Fourth-Quarter and Full-Year 2025 Results",
      "id": 139054717,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today reported its financial results for the fourth quarter and full year 2025.",
      "url": "https://finnhub.io/api/news?id=b09da6017c07450a4b48b89ecf0eeedaa5000dbcd3a9f712c8a48b0ae555a78c"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services, Inc. 2025 Q4 - Results - Earnings Call Presentation",
    "summary": "2026-02-12. The following slide deck was published by West Pharmaceutical Services, Inc.",
    "url": "https://finnhub.io/api/news?id=fa5ad7d94235a6f1a0483367ca718769c6deecd18f3b98f3736168f5bb4682ed",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770885210,
      "headline": "West Pharmaceutical Services, Inc. 2025 Q4 - Results - Earnings Call Presentation",
      "id": 139055202,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "WST",
      "source": "SeekingAlpha",
      "summary": "2026-02-12. The following slide deck was published by West Pharmaceutical Services, Inc.",
      "url": "https://finnhub.io/api/news?id=fa5ad7d94235a6f1a0483367ca718769c6deecd18f3b98f3736168f5bb4682ed"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Servs Sees FY2026 GAAP EPS $7.79-$8.14 vs $7.74 Est",
    "summary": "West Pharmaceutical Servs (NYSE:WST) is looking for FY2026 GAAP EPS of $7.79-$8.14 vs $7.74 analyst estimate..",
    "url": "https://finnhub.io/api/news?id=fcab42be174b5a7b4c7c835d09de93225562da44b1317d5e102ade6f8985156d",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770882273,
      "headline": "West Pharmaceutical Servs Sees FY2026 GAAP EPS $7.79-$8.14 vs $7.74 Est",
      "id": 139055703,
      "image": "",
      "related": "WST",
      "source": "Benzinga",
      "summary": "West Pharmaceutical Servs (NYSE:WST) is looking for FY2026 GAAP EPS of $7.79-$8.14 vs $7.74 analyst estimate..",
      "url": "https://finnhub.io/api/news?id=fcab42be174b5a7b4c7c835d09de93225562da44b1317d5e102ade6f8985156d"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Servs Sees FY2026 Adj EPS $7.85-$8.20 vs $7.78 Est; Sees Sales $3.215B-$3.275B vs $3.254B Est",
    "summary": "West Pharmaceutical Servs (NYSE:WST) is looking for FY2026 Adj EPS of $7.85-$8.20 vs $7.78 analyst estimate. sees sales of $3.215 billion-$3.275 billion vs $3.254 billion analyst estimate.",
    "url": "https://finnhub.io/api/news?id=4ccba22bf0d7cd29d15173b053849a89203bbc807ae8ec7ed891316710f806e8",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770882212,
      "headline": "West Pharmaceutical Servs Sees FY2026 Adj EPS $7.85-$8.20 vs $7.78 Est; Sees Sales $3.215B-$3.275B vs $3.254B Est",
      "id": 139055704,
      "image": "",
      "related": "WST",
      "source": "Benzinga",
      "summary": "West Pharmaceutical Servs (NYSE:WST) is looking for FY2026 Adj EPS of $7.85-$8.20 vs $7.78 analyst estimate. sees sales of $3.215 billion-$3.275 billion vs $3.254 billion analyst estimate.",
      "url": "https://finnhub.io/api/news?id=4ccba22bf0d7cd29d15173b053849a89203bbc807ae8ec7ed891316710f806e8"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Servs Q4 Earnings Summary & Key Takeaways",
    "summary": "",
    "url": "https://finnhub.io/api/news?id=556b7585efa460ae085908e368a1a42f3175b5b389e5b5dcfea15c450f567df6",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770882126,
      "headline": "West Pharmaceutical Servs Q4 Earnings Summary & Key Takeaways",
      "id": 139055705,
      "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/analyst_ratings_2.jpg?width=2048&height=1536",
      "related": "WST",
      "source": "Benzinga",
      "summary": " ",
      "url": "https://finnhub.io/api/news?id=556b7585efa460ae085908e368a1a42f3175b5b389e5b5dcfea15c450f567df6"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Servs Q4 Adj. EPS $2.04 Beats $1.83 Estimate, Sales $805.000M Beat $794.377M Estimate",
    "summary": "West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.04 per share which beat the analyst consensus estimate of $1.83 by 11.35 percent. This is a 12.09 percent increase over earnings of $1.82 per share",
    "url": "https://finnhub.io/api/news?id=7b082b55cfb7f1c362b2dd94dcf0ff88216e371fb4a62cacc80be666d9d1f57a",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770882072,
      "headline": "West Pharmaceutical Servs Q4 Adj. EPS $2.04 Beats $1.83 Estimate, Sales $805.000M Beat $794.377M Estimate",
      "id": 139055706,
      "image": "",
      "related": "WST",
      "source": "Benzinga",
      "summary": "West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.04 per share which beat the analyst consensus estimate of $1.83 by 11.35 percent. This is a 12.09 percent increase over earnings of $1.82 per share",
      "url": "https://finnhub.io/api/news?id=7b082b55cfb7f1c362b2dd94dcf0ff88216e371fb4a62cacc80be666d9d1f57a"
    }
  },
  {
    "ts": null,
    "headline": "54 Stocks, 9 Megatrends: My Favorite Places To Be While Capital Is 'Forced'",
    "summary": "My top-down strategy targets mission-critical sectors where capital is forced by secular and cyclical tailwinds. Check out the list of actionable stock picks here.",
    "url": "https://finnhub.io/api/news?id=8c93ce1a07c0d054c73c6fc4e2314fc285ad939f487e05d175d79bc55224e462",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770881400,
      "headline": "54 Stocks, 9 Megatrends: My Favorite Places To Be While Capital Is 'Forced'",
      "id": 139054949,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2239256494/image_2239256494.jpg?io=getty-c-w1536",
      "related": "WST",
      "source": "SeekingAlpha",
      "summary": "My top-down strategy targets mission-critical sectors where capital is forced by secular and cyclical tailwinds. Check out the list of actionable stock picks here.",
      "url": "https://finnhub.io/api/news?id=8c93ce1a07c0d054c73c6fc4e2314fc285ad939f487e05d175d79bc55224e462"
    }
  },
  {
    "ts": null,
    "headline": "Earnings Scheduled For February 12, 2026",
    "summary": "",
    "url": "https://finnhub.io/api/news?id=4fd3756cb1814eaf3610e5b762de807b1939a478aa9530d3d91c54b5f01eb6f1",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770880293,
      "headline": "Earnings Scheduled For February 12, 2026",
      "id": 139055272,
      "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/earnings_scheduled_1.jpg?width=2048&height=1536",
      "related": "WST",
      "source": "Benzinga",
      "summary": " ",
      "url": "https://finnhub.io/api/news?id=4fd3756cb1814eaf3610e5b762de807b1939a478aa9530d3d91c54b5f01eb6f1"
    }
  }
]